Coronary Stent Market Size, Share & Trend Analysis Report by Product (Bare Metal Stents, Drug Eluting Stents, Bioresorbable Vascular Scaffold), And Segment Forecasts, 2013 - 2024

Published: Mar, 2018 | Pages: 82 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)

The global coronary stents market is expected to reach USD 15.18 billion by 2025, according to a new report by Grand View Research, Inc. Rising prevalence of coronary artery diseases, supportive government reforms and increasing awareness are contributing factors for lucrative growth of coronary stents

The latest treatments available in cardiac care are expected to increase the life span of the elderly population subset. This demographic is characterized with low immunity levels and are prone to chronic diseases including CVDs. Thus, increasing geriatric population is thereby considered as a high impact rendering driver for the growth of this industry over the forecast period.

The coronary stent market is driven by reimbursement coverage provided by the general public Center for Medicare & Medicaid Services (CMS) and private payers. The coverage is availed under national coverage determination for carotid artery stenting, including products and service provider. The providers require completing certain conditions for coverage, all facilities to be certified by CMS to perform CAS procedures.

Reimbursement of medical devices is limited to the developed regions of Asia Pacific. For instance, Japan's National Health Insurance system provides reimbursement for all medical devices. However, some countries in the Asia Pacific region have no scope for reimbursement and the patients themselves incur the expenses while the unprivileged ones often forego treatment, thus restraining the growth of this vertical in certain countries.

Further key findings from the study suggest:

• DES held lucrative share in 2015. Avoidance of complications, ease of procedures and comfort to the patient are factors responsible for increased usage rate.

• BVS are anticipated to growth exponential over the forecast period due to the added advantages such as restoring vasomotor function, and fewer complications offered by the product.

• North America held substantial share in global coronary stents market. Sophisticated healthcare system, well planned reimbursement program, high healthcare expenditure and large pool of target population are responsible for the region's substantial share.

• Asia Pacific is anticipated to exhibit lucrative growth over the forecast period. Economic developments and government reforms especially in countries like India and China are supporting the growth of this region.

 Table of Contents

Chapter 1 Research Methodology
                  1.1 Research Methodology
                  1.2 Research Scope & Assumptions
                  1.3 List of Data Sources
Chapter 2 Executive Summary
Chapter 3 Market Summary
Chapter 4 Market Variables, Trends & Scope
                  4.1 Market Segmentation & Scope
                  4.2 Market Driver Analysis
                  4.3 Market Restraint Analysis
                  4.4 Penetration & Growth Prospect Mapping
                  4.5 SWOT Analysis, By Factor
                     4.5.1 Political
                     4.5.2 Economic
                     4.5.3 Technology
Chapter 5 Market Categorization 1: Product Estimates & Trend Analysis 
                  5.1 Product Movement Analysis & Market Share, 2015 & 2024
                  5.2 Market Size & Forecasts and Trend Analyses, 2013 to 2024 For the Following Products:
                     5.2.1 Bare metal stents
                     5.2.2 Drug-eluting stents
                           5.2.2.1 Biodegradable 
                           5.2.2.2 Non-biodegradable 
                     5.2.3 Bioresorbable vascular scaffold 
Chapter 6 Market Categorization 2: Regional Estimates & Trend Analysis
                  6.1 Regional Movement Analysis & Market Share, 2015 & 2024
                  6.2 Market Size & Forecasts and Trend Analyses, 2013 to 2024 for the following regions:
                     6.2.1 North America
                           6.2.1.1 U.S.
                           6.2.1.2 Canada
                     6.2.2 Europe
                           6.2.2.1 UK
                           6.2.2.2 Germany
                     6.2.3 Asia Pacific
                           6.2.3.1 Japan
                           6.2.3.2 China
                     6.2.4 Latin America
                           6.2.4.1 Brazil
                           6.2.4.2 Mexico
                     6.2.5 MEA
                           6.2.5.1 South Africa
Chapter 7 Competitive Landscape
                  7.1 Strategy Framework
                  7.2 Company Profiles
                     7.2.1 Abbott 
                           7.2.1.1 Company overview
                           7.2.1.2 Financial performance
                           7.2.1.3 Product benchmarking
                           7.2.1.4 Strategic initiatives
                     7.2.2 Boston Scientific Corportaion 
                           7.2.2.1 Company overview
                           7.2.2.2 Financial performance
                           7.2.2.3 Product benchmarking
                           7.2.2.4 Strategic initiatives
                     7.2.3 Medtronic
                           7.2.3.1 Company overview
                           7.2.3.2 Financial performance
                           7.2.3.3 Product benchmarking
                           7.2.3.4 Strategic initiatives
                     7.2.4 Terumo Corporation
                           7.2.4.1 Company overview
                           7.2.4.2 Financial performance
                           7.2.4.3 Product benchmarking
                           7.2.4.4 Strategic initiatives
                     7.2.5 B. Braun Melsungen AG
                           7.2.5.1 Company overview
                           7.2.5.2 Financial performance
                           7.2.5.3 Product benchmarking
                           7.2.5.4 Strategic initiatives
                     7.2.6 Biotronik SE & Co. KG
                           7.2.6.1 Company overview
                           7.2.6.2 Financial performance
                           7.2.6.3 Product benchmarking
                           7.2.6.4 Strategic initiatives
                     7.2.7 Stentys SA
                           7.2.7.1 Company overview
                           7.2.7.2 Financial performance
                           7.2.7.3 Product benchmarking
                           7.2.7.4 Strategic initiatives
                     7.2.8 MicroPort Scientific Corporation
                           7.2.8.1 Company overview
                           7.2.8.2 Financial performance
                           7.2.8.3 Product benchmarking
                           7.2.8.4 Strategic initiatives
                     7.2.9 C. R. Bard, Inc.
                           7.2.9.1 Company overview
                           7.2.9.2 Financial performance
                           7.2.9.3 Product benchmarking
                           7.2.9.4 Strategic initiatives
                     7.2.10 Cook Medical
                           7.2.10.1 Company overview
                           7.2.10.2 Financial performance
                           7.2.10.3 Product benchmarking
                           7.2.10.4 Strategic initiatives

List of Tables

TABLE 1 North America coronary stent market, by product, 2013 - 2024 (USD Million)
TABLE 2 North America drug eluting stents market, by product, 2013 - 2024 (USD Million)
TABLE 3 U.S. coronary stent market, by product, 2013 - 2024 (USD Million)
TABLE 4 U.S. drug eluting stents market, by product, 2013 - 2024 (USD Million)
TABLE 5 Canada coronary stent market, by product, 2013 - 2024 (USD Million)
TABLE 6 Canada drug eluting stents market, by product, 2013 - 2024 (USD Million)
TABLE 7 Europe coronary stent market, by product, 2013 - 2024 (USD Million)
TABLE 8 Europe drug eluting stents market, by product, 2013 - 2024 (USD Million)
TABLE 9 UK coronary stent market, by product, 2013 - 2024 (USD Million)
TABLE 10 UK drug eluting stents market, by product, 2013 - 2024 (USD Million)
TABLE 11 Germany coronary stent market, by product, 2013 - 2024 (USD Million)
TABLE 12 Germany drug eluting stents market, by product, 2013 - 2024 (USD Million)
TABLE 13 Asia Pacific coronary stent market, by product, 2013 - 2024 (USD Million)
TABLE 14 Asia Pacific drug eluting stents market, by product, 2013 - 2024 (USD Million)
TABLE 15 China coronary stent market, by product, 2013 - 2024 (USD Million)
TABLE 16 China drug eluting stents market, by product, 2013 - 2024 (USD Million)
TABLE 17 Japan coronary stent market, by product, 2013 - 2024 (USD Million)
TABLE 18 Japan drug eluting stents market, by product, 2013 - 2024 (USD Million)
TABLE 19 Latin America coronary stent market, by product, 2013 - 2024 (USD Million)
TABLE 20 Latin America drug eluting stents market, by product, 2013 - 2024 (USD Million)
TABLE 21 Brazil coronary stent market, by product, 2013 - 2024 (USD Million)
TABLE 22 Brazil drug eluting stents market, by product, 2013 - 2024 (USD Million)
TABLE 23 Mexico coronary stent market, by product, 2013 - 2024 (USD Million)
TABLE 24 Mexico drug eluting stents market, by product, 2013 - 2024 (USD Million)
TABLE 25 MEA coronary stent market, by product, 2013 - 2024 (USD Million)
TABLE 26 MEA drug eluting stents market, by product, 2013 - 2024 (USD Million)
TABLE 27 South Africa America coronary stent market, by product, 2013 - 2024 (USD Million)
TABLE 28 South Africa drug eluting stents market, by product, 2013 - 2024 (USD Million)

List of Figures

FIG. 1 Market summary 
FIG. 2 Market trends & outlook 
FIG. 3 Market segmentation & scope 
FIG. 4 Market driver relevance analysis (Current & future impact) 
FIG. 5 Market restraint relevance analysis (Current & future impact) 
FIG. 6 Penetration & growth prospect mapping 
FIG. 7 SWOT Analysis, by factor (Political & legal, economic and technological) 
FIG. 8 Porter's Five Forces Analysis 
FIG. 9 Coronary stent market product outlook: Key takeaways 
FIG. 10 Coronary stents : Product movement analysis 
FIG. 11 Bare metal stents market, 2013 - 2024 (USD Million) 
FIG. 12 Drug eluting stents market, 2013 - 2024 (USD Million) 
FIG. 13 Biodegradable drug eluting stents market, 2013 - 2024 (USD Million) 
FIG. 14 Non-biodegradable drug eluting stents market, 2013 - 2024 (USD Million) 
FIG. 15 Bioresorbable vascular sacaffold market, 2013 - 2024 (USD Million) 
FIG. 16 North America coronary stent market, 2013 - 2024 (USD Million) 
FIG. 17 U.S. coronary stent market, 2013 - 2024 (USD Million)
FIG. 18 Canada coronary stent market, 2013 - 2024 (USD Million)
FIG. 19 Europe coronary stent market, 2013 - 2024 (USD Million)
FIG. 20 UK coronary stent market, 2013 - 2024 (USD Million)
FIG. 21 Germany coronary stent market, 2013 - 2024 (USD Million)
FIG. 22 Asia Pacific coronary stent market, 2013 - 2024 (USD Million)
FIG. 23 Japan coronary stent market, 2013 - 2024 (USD Million)
FIG. 24 China coronary stent market, 2013 - 2024 (USD Million)
FIG. 25 Latin America coronary stent market, 2013 - 2024 (USD Million)
FIG. 26 Brazil coronary stent market, 2013 - 2024 (USD Million)
FIG. 27 Mexico coronary stent market, 2013 - 2024 (USD Million)
FIG. 28 MEA coronary stent market, 2013 - 2024 (USD Million)
FIG. 29 Saudi Arabia coronary stent market, 2013 - 2024 (USD Million)